Sign Up
Contact

Program Development

Developing Novel Treatments Through Microbiome Testing

Creating Microbial-Based Products To Treat Mental Illness

Taylored Biotherapeutics is a platform company researching and developing novel treatments for a variety of mental illnesses. Our research has found a significant association between the health of the brain and the gut microbiome, allowing us to tailor treatments for different illnesses.

Taylored Biotherapeutics is a neuroscience led company informed by some of the only clinical fecal transplant studies for mental illness in the world. This has supported a precision medicine approach to developing microbial therapeutics.

Current Pipeline

Product NameSafety and Efficacy TestingBacterial Tracing CharacterizationPrototype DevelopmentPhase I
TBIBipDep-01✓ Completed✓ Completed✓ CompletedProtocol Development
TBIDepression-02Ongoing. Anticipated end date: Q3 2023PlannedPlannedProtocol Development
TBIOCD-03Ongoing. Anticipated end date: Q2 2023PlannedPlannedProtocol Development

Data has been accrued in our developmental biobank for ADHD, Dementia, and Psychosis

See Our Lab

Researchers at Taylor Lab are discovering how the human microbiome impacts mental health.

Receive the latest news

Join Our Journey

Be the First to Know: Unlock exclusive updates on the progress and launch timeline of our groundbreaking biotherapeutics product development.

Name(Required)
Close

Asem Bala

MSc

Asem Bala, MSc has over 20 years of experience in Healthcare & Clinical Research Management, now working at Taylored Biotherapeutics to create partnerships and ensure regulatory approvals.

Close

Dr. Valerie Taylor

MD, PhD, FRCP

Dr. Valerie Taylor, MD, PhD, FRCP is a Professor of Psychiatry at the University of Calgary. She completed a Bachelor of Medical Science and graduated from medical school at Memorial University of Newfoundland. She subsequently finished her residency training in Psychiatry and got her PhD in Neuroscience from McMaster University in Hamilton, Ontario. Prior to coming to Calgary, she was the chief of Psychiatry at the Women’s College Hospital and the chief of Adult Health Services at the Center for Addiction and Mental Health in Toronto.

Her academic focus has been on the area of medical psychiatry – specifically, for the last 5 years, on the gut brain axis and the the gut microbiome. She is the only funded researcher in North America examining the therapeutic effects of fecal transplant as a treatment for mental health and she currently has 4 novel clinical trials looking at modifying the gut microbiome to treat mood disorders as well as the largest biological neuroscience microbiome repository in North America. She has over 180 peer reviewed publications and funding from a variety of national and international funding agencies. In 2020 she started Taylored Biotherapeutics, a micro therapeutics drug company. Today her primary role is in leading product development, getting regulatory approval, and finding partnerships.